Torthaí cuardaigh - Winston X. Yan

  • 1 - 19 toradh as 19 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Reducing the gradient artefact in simultaneous EEG-fMRI by adjusting the subject's axial position

    Reducing the gradient artefact in simultaneous EEG-fMRI by adjusting the subject's axial position de réir Karen J. Mullinger, Winston X. Yan, Richard Bowtell

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action

    A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action de réir Shiran Abadi, Winston X. Yan, David Amar, Itay Mayrose

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Physical modeling of pulse artefact sources in simultaneous EEG/fMRI

    Physical modeling of pulse artefact sources in simultaneous EEG/fMRI de réir Winston X. Yan, Karen J. Mullinger, Gerða Björk Geirsdóttir, Richard Bowtell

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Rationally engineered Cas9 nucleases with improved specificity

    Rationally engineered Cas9 nucleases with improved specificity de réir Ian M. Slaymaker, Linyi Gao, Bernd Zetsche, David Scott, Winston X. Yan, Feng Zhang

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein

    Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein de réir Winston X. Yan, Shaorong Chong, Huaibin Zhang, Kira S. Makarova, Eugene V. Koonin, David R. Cheng, David Scott

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    CRISPR–Cas in mobile genetic elements: counter-defence and beyond

    CRISPR–Cas in mobile genetic elements: counter-defence and beyond de réir Guilhem Faure, Sergey Shmakov, Winston X. Yan, David R. Cheng, David Scott, Joseph E. Peters, Kira S. Makarova, Eugene V. Koonin

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Crystal Structure of Staphylococcus aureus Cas9

    Crystal Structure of Staphylococcus aureus Cas9 de réir Hiroshi Nishimasu, Le Cong, Winston X. Yan, F. Ann Ran, Bernd Zetsche, Yinqing Li, Arisa Kurabayashi, Ryuichiro Ishitani, Feng Zhang, Osamu Nureki

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Engineered Cpf1 variants with altered PAM specificities

    Engineered Cpf1 variants with altered PAM specificities de réir Linyi Gao, David Cox, Winston X. Yan, John C. Manteiga, Martin Schneider, Takashi Yamano, Hiroshi Nishimasu, Osamu Nureki, Nicola Crosetto, Feng Zhang

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides

    Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides de réir Annemieke Aartsma‐Rus, Alejandro Garanto, Willeke M. C. van Roon‐Mom, Erin M. McConnell, Victoria Suslovitch, Winston X. Yan, Jonathan K. Watts, Timothy W. Yu

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Functionally diverse type V CRISPR-Cas systems

    Functionally diverse type V CRISPR-Cas systems de réir Winston X. Yan, Pratyusha Hunnewell, Lauren E. Alfonse, Jason Carte, Elise Keston-Smith, Shanmugapriya Sothiselvam, Anthony J. Garrity, Shaorong Chong, Kira S. Makarova, Eugene V. Koonin, David R. Cheng, David Scott

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    In vivo genome editing using Staphylococcus aureus Cas9

    In vivo genome editing using Staphylococcus aureus Cas9 de réir F. Ann Ran, Le Cong, Winston X. Yan, David Scott, Jonathan S. Gootenberg, Andrea J. Kriz, Bernd Zetsche, Ophir Shalem, Xuebing Wu, Kira S. Makarova, Eugene V. Koonin, Phillip A. Sharp, Feng Zhang

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Diversity and evolution of class 2 CRISPR–Cas systems

    Diversity and evolution of class 2 CRISPR–Cas systems de réir Sergey Shmakov, Aaron A. Smargon, David Scott, David Cox, Neena Pyzocha, Winston X. Yan, Omar O. Abudayyeh, Jonathan S. Gootenberg, Kira S. Makarova, Yuri I. Wolf, Konstantin Severinov, Feng Zhang, Eugene V. Koonin

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks

    BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks de réir Winston X. Yan, Reza Mirzazadeh, Silvano Garnerone, David Scott, Martin Schneider, Tomasz Kallas, Joaquín Custodio, Erik Wernersson, Yinqing Li, Linyi Gao, Yana Federova, Bernd Zetsche, Feng Zhang, Magda Bienko, Nicola Crosetto

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    CRISPR-Cas9–based treatment of myocilin-associated glaucoma

    CRISPR-Cas9–based treatment of myocilin-associated glaucoma de réir Ankur Jain, Gulab Zode, Ramesh B. Kasetti, F. Ann Ran, Winston X. Yan, Tasneem Putliwala Sharma, Kevin Bugge, Charles Searby, John H. Fingert, Feng Zhang, Abbot F. Clark, Val C. Sheffield

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    In vivo gene editing in dystrophic mouse muscle and muscle stem cells

    In vivo gene editing in dystrophic mouse muscle and muscle stem cells de réir Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng, Wei Leong Chew, Jeffrey J. Widrick, Winston X. Yan, Claire Maesner, Elizabeth Y. Wu, Ru Xiao, F. Ann Ran, Le Cong, Feng Zhang, Luk H. Vandenberghe, George M. Church, Amy J. Wagers

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

    In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy de réir Christopher E. Nelson, Chady H. Hakim, David G. Ousterout, Pratiksha I. Thakore, Eirik A. Moreb, Ruth M. Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F. Ann Ran, Winston X. Yan, Aravind Asokan, Feng Zhang, Dongsheng Duan, Charles A. Gersbach

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    The miniature CRISPR-Cas12m effector binds DNA to block transcription

    The miniature CRISPR-Cas12m effector binds DNA to block transcription de réir Wen Y. Wu, Prarthana Mohanraju, Chunyu Liao, Belén Adiego-Pérez, Sjoerd C.A. Creutzburg, Kira S. Makarova, Karlijn Keessen, Timon A. Lindeboom, Tahseen S. Khan, Stijn H. P. Prinsen, Rob Joosten, Winston X. Yan, Anzhela Migur, Charlie Laffeber, David Scott, Joyce H.G. Lebbink, Eugene V. Koonin, Chase L. Beisel, John van der Oost

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing

    Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing de réir Colin McGaw, Anthony J. Garrity, Gabrielle Munoz, Jeffrey R. Haswell, Sejuti Sengupta, Elise Keston-Smith, Pratyusha Hunnewell, Alexa Ornstein, Mishti Bose, Quinton N. Wessells, Noah Jakimo, Paul Yan, Huaibin Zhang, Lauren E. Alfonse, Roy Ziblat, Jason Carte, Weicheng Lu, Derek Cerchione, Brendan J. Hilbert, Shanmugapriya Sothiselvam, Winston X. Yan, David R. Cheng, David Scott, Tia DiTommaso, Shaorong Chong

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants

    Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants de réir Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo, Sergey Shmakov, Omer S. Alkhnbashi, Stan J. J. Brouns, Emmanuelle Charpentier, David R. Cheng, Daniel H. Haft, Philippe Horvath, Sylvain Moineau, Francisco J. M. Mojica, David Scott, Shiraz A. Shah, Virginijus Šikšnys, Michael P. Terns, Česlovas Venclovas, Malcolm F. White, Alexander F. Yakunin, Winston X. Yan, Feng Zhang, Roger A. Garrett, Rolf Backofen, John van der Oost, Rodolphe Barrangou, Eugene V. Koonin

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: